Thinly traded micro cap IMV NASDAQIMV is up53premarket on light volume in response to its announced plan to develop a COVID19 vaccine based on its lipidbased delivery platform called DPXIt will collaborate with Joanne Langley MD andScott Halper 449 chars<ul><li>Thinly traded micro cap IMV (NASDAQ:<a href='https://seekingalpha.com/symbol/IMV' title='IMV Inc.'>IMV</a>) is up <font color="green">53%</font> premarket on light volume in response to its <a href="https://seekingalpha.com/pr/17812181-imv-inc-launche…IMV up 53 premarket on coronavirus vaccine plan